ViroPharma Receives Complete Response Letter for Cinryze

ViroPharma Incorporated announced the U.S. Food and Drug Administration issued a complete response letter regarding Cinryze (C1 Esterase Inhibitor [Human]) industrial scale manufacturing expansion activities.
heraldonline